Audience Q&A

Every Cell & Gene Live dedicates time to answering real-time questions from the audience. During “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned,” panelists Will Junker, Head of Vector Manufacturing Quality at Kite Pharma and Mitch Lower, SVP of Technical Operations at Kriya Therapeutics provided thoughtful and detailed responses to audience questions on everything from utilizing pre-fab units, exit strategies, risk mitigation, and much more.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online